Medacta06.05.20
Medacta has obtained CE marking for its Long Humeral Diaphysis and Stemless Humeral Metaphysis implants for shoulder joint replacement.
The Long Humeral Diaphysis, which recently obtained clearance from the FDA for use in the U.S., can help surgeons facing complex cases of shoulder replacement, particularly when there is a need for extended distal fixation.
The Stemless Humeral Metaphysis is intended for use in anatomic configuration and enables a minimally invasive approach at the humeral level, preserving the humeral canal. The Stemless Humeral Metaphysis features Medacta's 3D Metal surface, an advanced, 3D-printed structure designed to improve the metal-bone mechanical bond.
Medacta collaborated with several expert surgeons to develop its new options for shoulder replacement. Prof. Dr. Bernhard Jost, chief of department / head shoulder-elbow, Department of Orthopaedics and Traumatology, Kantonsspital St. Gallen, Switzerland, is one of the designers and has worked closely with Medacta's engineers on the successful development of both the Long Humeral Diaphysis and Stemless Humeral Metaphysis.
“With these two additional components, the Medacta Shoulder System becomes more complete, allowing surgeons to widen their clinical use of the system by addressing more patient morphologies and pathologies,” said Jost.
Francesco Siccardi, CEO of Medacta stated, “With the new Stemless Humeral Metaphysis, Medacta is now able to offer a minimally invasive solution for shoulder arthroplasty and continue our commitment to improve the care and well-being of orthopedic patients around the world.”
Responsible Introduction to the Market
The Long Humeral Diaphysis and Stemless Metaphysis will be introduced in select hospitals following the guidelines of Medacta's M.O.R.E. Excellence Clinical Program. With the goal of responsibly introducing innovative products to the market, Medacta releases new products on a restricted basis to conduct voluntary clinical programs in order to further document and confirm their efficacy.
Both implants are part of the Medacta Shoulder System, a shoulder replacement system that features a range of options. As a modular system, the Medacta Shoulder System offers the flexibility to move, if necessary, from a hemi-arthroplasty to a total or reverse arthroplasty. Since the implants are compatible and work in conjunction with each other, this system is complete and convertible. With these new implants, the Medacta Shoulder System becomes even more robust with a range of stemless, short, standard, and long stems.
The Long Humeral Diaphysis, which recently obtained clearance from the FDA for use in the U.S., can help surgeons facing complex cases of shoulder replacement, particularly when there is a need for extended distal fixation.
The Stemless Humeral Metaphysis is intended for use in anatomic configuration and enables a minimally invasive approach at the humeral level, preserving the humeral canal. The Stemless Humeral Metaphysis features Medacta's 3D Metal surface, an advanced, 3D-printed structure designed to improve the metal-bone mechanical bond.
Medacta collaborated with several expert surgeons to develop its new options for shoulder replacement. Prof. Dr. Bernhard Jost, chief of department / head shoulder-elbow, Department of Orthopaedics and Traumatology, Kantonsspital St. Gallen, Switzerland, is one of the designers and has worked closely with Medacta's engineers on the successful development of both the Long Humeral Diaphysis and Stemless Humeral Metaphysis.
“With these two additional components, the Medacta Shoulder System becomes more complete, allowing surgeons to widen their clinical use of the system by addressing more patient morphologies and pathologies,” said Jost.
Francesco Siccardi, CEO of Medacta stated, “With the new Stemless Humeral Metaphysis, Medacta is now able to offer a minimally invasive solution for shoulder arthroplasty and continue our commitment to improve the care and well-being of orthopedic patients around the world.”
Responsible Introduction to the Market
The Long Humeral Diaphysis and Stemless Metaphysis will be introduced in select hospitals following the guidelines of Medacta's M.O.R.E. Excellence Clinical Program. With the goal of responsibly introducing innovative products to the market, Medacta releases new products on a restricted basis to conduct voluntary clinical programs in order to further document and confirm their efficacy.
Both implants are part of the Medacta Shoulder System, a shoulder replacement system that features a range of options. As a modular system, the Medacta Shoulder System offers the flexibility to move, if necessary, from a hemi-arthroplasty to a total or reverse arthroplasty. Since the implants are compatible and work in conjunction with each other, this system is complete and convertible. With these new implants, the Medacta Shoulder System becomes even more robust with a range of stemless, short, standard, and long stems.
